Table 5.
Incidence of HGD/EAC in the cohort considering surveillance time calculation methodology used by population-based studies
| Variable | n | Total Surveillance |
|||
|---|---|---|---|---|---|
| Person-years at risk, n | Events in study cohort, n | Incidence rate/1000 Person-yrs (95% CI) | |||
| Total cohort | 331 | 3537 | 8 | 2.2 (1.0–4.3) | |
| Gender | Male | 251 | 2605 | 8 | 3.1 (1.4–5.8) |
| Female | 80 | 932 | 0 | – | |
| Length (cm) | ≤ 3 cm | 208 | 2304 | 1 | 0.4 (0.2–2.4) |
| > 3 and ≤ 6 cm | 90 | 859 | 3 | 3.5 (0.9–9.5) | |
| > 6 cm | 33 | 374 | 4 | 10.7 (4.0–28.5) | |
| Length | Short | 208 | 2304 | 1 | 0.4 (0.2–2.4) |
| Long | 123 | 1233 | 7 | 5.7 (2.5–11.2) | |